News
EUROPEAN shares declined on Wednesday as investors awaited the Federal Reserve’s monetary policy decision, with ongoing tensions in the Middle East adding to market uncertainty. Read more at The ...
Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...
A MOTHER has revealed that she lost over eight stone whilst using Mounjaro, but has been accused of “cheating” her weight loss. Not only this, but Kelsey, the mum from Glasgow, has constantly ...
WITH Mounjaro users shedding nearly double the amount of weight compared to its other counterparts, it’s no wonder the ...
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
It was desperation to lose the stubborn three stone in baby weight I'd put on after two children that first led me to ...
“GLP-1 drugs don’t just curb appetite – they dull the desire to drink at a metabolic level. With cravings suppressed and ...
11h
Zacks Investment Research on MSNCan Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space?Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...
Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...
It's estimated that around 1.5 million Brits are now taking weight-loss drugs, such as Wegovy, Ozempic, Mounjaro, Saxenda and Orlistat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results